For many years, radical gender ideologues have pushed their toxic agenda by promoting the emotional blackmail argument that, if we don’t allow children to be harmed for life with puberty-blockers, cross-sex hormones and mutilating surgeries, the children will kill themselves.

It’s always been an insane lie, and now we have the proof!

A new study has found that there is no evidence to support the claim that suicides among young patients rose sharply since puberty-blocking drugs were restricted in Britain.

The independent review was conducted by Professor Louis Appleby, who also added that discussion of the issue on social media has been “insensitive, distressing and dangerous”.

“One risk is that young people and their families will be terrified by predictions of suicide without puberty blockers". 

-Prof Louis Appleby, independent reviewer

Britain’s Health Secretary Wes Streeting appointed Appleby, professor of psychiatry and suicide researcher at the University of Manchester, to review National Health Service (NHS) data on suicides by young patients of the now-closed Gender Identity Development Service (GIDS) at the Tavistock and Portman NHS Foundation Trust.

Trans-promoting organizations, amplified by many in the mainstream media, had claimed that there had been “an explosion” of suicides following the restriction of puberty blockers to gender dysphoria patients in December, 2020.

Appleby’s review has proven these claims false, finding that there was “…essentially no difference” in the numbers of suicides in the three years leading up to the restriction, and the three years that followed that restriction.

This report comes as yet another lethal blow to gender transition radicals.

 In April of this year the Cass Review used evidence, not ideology, to expose the catastrophic failures of Britain’s National Health Service (NHS) to meet the needs of vulnerable, gender-confused children, and concluded that there was “remarkably weak evidence” to support “gender transition” treatments for children.

It’s wonderful to see leadership pursuing a return to evidence-based conclusions in care decisions for young people affected by gender confusion, in Britain at least.

Sadly, Canada is years behind the times, and the emotional blackmail of “it’s better to have a trans daughter than a dead son” still holds sway here with the medical and political establishments. 

We must keep up the pressure to ensure the rational, measured and evidence-based conclusions of reports like Professor Appleby’s find their way to Canada, and influence the care of our children.